These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 4083641)

  • 1. [Death during treatment with ellipticine].
    Grossman C; Cacoub P; Guillevin L; Royer I
    Ann Med Interne (Paris); 1985; 136(6):519. PubMed ID: 4083641
    [No Abstract]   [Full Text] [Related]  

  • 2. [Elliptinium acetate and the nephrotic syndrome].
    Pulik M; Dreyfus F; Varet B; Schneider P
    Nephrologie; 1986; 7(4):172-3. PubMed ID: 3796788
    [No Abstract]   [Full Text] [Related]  

  • 3. [Fatal complication during treatment with elliptinium acetate].
    Pedinielli FJ; Routy JP; Blanc AP; Garrigues B
    Presse Med; 1985 Jan; 14(2):104. PubMed ID: 3156319
    [No Abstract]   [Full Text] [Related]  

  • 4. [Renal toxicity of 9-hydroxy-2-methylellipticinium].
    Ryckelynck JP; Heron JF; Juret P; De Ranieri E; Herlin P; Hardouin A; Le Talaer JY
    Presse Med; 1984 Jan; 13(2):104. PubMed ID: 6229731
    [No Abstract]   [Full Text] [Related]  

  • 5. [Renal toxicity of 9-hydroxy-2-methyl-ellipticinium].
    Ryckelynck JP; Heron JF; Juret P; Schneider P; Herlin P; De Ranieri E; Hardouin A; Peny J; Le Talaer JY
    Nephrologie; 1984; 5(2):59-63. PubMed ID: 6483073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [N-Methyl-9 hydroxy-ellipticine (NSC 264-137) in the treatment of malignant metastases. Preliminary results (author's transl)].
    Rouesse J; Tursz T; Le Chevalier T; Huertas D; Amiel JL; Brule G; Callet B; Droz JP; Voisin PM; Sancho-Garnier H; Le Pecq JB; Paoletti C
    Nouv Presse Med; 1981 May; 10(24):1997-9. PubMed ID: 7255136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-Methyl-9-hydroxyellipticinium acetate (ellipticinium) in the treatment of lymphomas. Preliminary results of a phase II study.
    Tura S; Mandelli F; Mazza P; Cimino G; Anselmo AP; Amadori S
    Chemioterapia; 1984 Apr; 3(2):79-82. PubMed ID: 6532540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [2 N methyl 9 hydroxy-ellipticine in treatment of metastatic breast cancers (author's transl)].
    Rouëssé J; Huertas D; Sancho-Garnier H; Le Chevalier T; Amiel JL; Brulé G; Tursz T; Mondésir JM
    Bull Cancer; 1981; 68(5):437-41. PubMed ID: 7037078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sanguinarine and ellipticine cytotoxic alkaloids isolated from well-known antitumor plants. Intracellular targets of their action].
    Faddeeva MD; Beliaeva TN
    Tsitologiia; 1997; 39(2-3):181-208. PubMed ID: 9312909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Syntheses designed to produce 8-amino ellipticine. Synthesis and pharmacological properties of 8-nitro ellipticine].
    Gansser C; Lévque X; Plat M; Viel C
    Farmaco Sci; 1982 May; 37(5):283-97. PubMed ID: 7095141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Metabolism and pharmacokinetics of methoxy-9-ellipticine and its principal metabolite, hydroxy-9-ellipticine].
    Lecointe P; Puget A
    C R Seances Acad Sci III; 1983; 296(6):279-82. PubMed ID: 6405990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Teratogenic effects of 9-hydroxy-ellipticine in mouse embryo].
    Cros S; Raynaud A
    C R Seances Acad Sci III; 1982 Oct; 295(7):465-70. PubMed ID: 6819062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ellipticine induces apoptosis through p53-dependent pathway in human hepatocellular carcinoma HepG2 cells.
    Kuo YC; Kuo PL; Hsu YL; Cho CY; Lin CC
    Life Sci; 2006 Apr; 78(22):2550-7. PubMed ID: 16337242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formation and persistence of DNA adducts of anticancer drug ellipticine in rats.
    Stiborová M; Rupertová M; Aimová D; Ryslavá H; Frei E
    Toxicology; 2007 Jul; 236(1-2):50-60. PubMed ID: 17482743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidation of an antitumor drug ellipticine by peroxidases.
    Poljaková J; Forsterová K; Sulc M; Frei E; Stiborová M
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Dec; 149(2):449-53. PubMed ID: 16601808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutagenicity and cytotoxicity of five antitumor ellipticines in mammalian cells and their structure-activity relationships in Salmonella.
    DeMarini DM; Cros S; Paoletti C; Lecointe P; Hsie AW
    Cancer Res; 1983 Aug; 43(8):3544-52. PubMed ID: 6344986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA adduct formation by the anticancer drug ellipticine in human leukemia HL-60 and CCRF-CEM cells.
    Poljaková J; Frei E; Gomez JE; Aimová D; Eckschlager T; Hrabeta J; Stiborová M
    Cancer Lett; 2007 Jul; 252(2):270-9. PubMed ID: 17306925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Structural study of an analog of ellipticine designed as antineoplastic, 1,4-dihydro-4-oxo-2,5,11-trimethyl-6H-pyrido[3,2-b]carbazole, with X-ray diffraction].
    Viossat B; Dung NH; Lancelot JC; Benazeth S; Rault S; Robba M
    Chem Pharm Bull (Tokyo); 1987 May; 35(5):1724-33. PubMed ID: 3664794
    [No Abstract]   [Full Text] [Related]  

  • 19. Oxidation pattern of the anticancer drug ellipticine by hepatic microsomes - similarity between human and rat systems.
    Stiborová M; Borek-Dohalská L; Aimová D; Kotrbová V; Kukacková K; Janouchová K; Rupertová M; Ryslavá H; Hudecek J; Frei E
    Gen Physiol Biophys; 2006 Sep; 25(3):245-61. PubMed ID: 17197724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vitro stimulation by ellipticine derivatives of DNA cleavage induced by DNA topoisomerase II: a structure-activity relationship].
    Fossé P; Charra M; Paoletti C; Saucier JM; René B
    Bull Cancer; 1994 Mar; 81(3):194-202. PubMed ID: 7894127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.